Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders

Nonhuman primates (NHPs) have provided robust experimental animal models for many human‐related diseases due to their similar physiologies. Nonetheless, profound differences remain in the acquisition, progression, and outcome of important diseases such as AIDS and Alzheimer's, for which the underlying basis remains obscure. We explored the utility of human high‐density oligonucleotide arrays to survey the transcription profile of NHP genomes. Total RNA from prefrontal cortices of human (Homo sapiens), common chimpanzee (Pan troglodytes), cynomolgous macaque (Macaca fascicularis), and common marmoset (Callithrix jacchus) was labeled and hybridized to Affymetrix U95A GeneChip probe arrays. Corresponding data obtained previously from common chimpanzee and orangutan (Pongo pygmaeus) were added for comparison. Qualitative (present or not detected) and quantitative (expression level) analysis indicated that many genes known to be involved in human neurological disorders were present and regulated in NHPs. A gene involved in dopamine metabolism (catechol‐O‐methyltransferase) was absent in macaque and marmoset. Glutamate receptor 2 was up‐regulated, and transcription‐associated genes were down‐regulated in NHPs compared with humans. We demonstrate that transcript profiling of NHPs could provide comparative genomic data to validate and better focus experimental animal models of human neurological disorders.

[1]  S. Pääbo,et al.  Intra- and Interspecific Variation in Primate Gene Expression Patterns , 2002, Science.

[2]  Jun Zou,et al.  Microarray profile of differentially expressed genes in a monkey model of allergic asthma , 2002, Genome Biology.

[3]  C. Tomaz,et al.  Non-human primate models for investigating fear and anxiety , 2002, Neuroscience & Biobehavioral Reviews.

[4]  Patrick R. Hof,et al.  Age-related changes in GluR2 and NMDAR1 glutamate receptor subunit protein immunoreactivity in corticocortically projecting neurons in macaque and patas monkeys , 2002, Brain Research.

[5]  S. Sugano,et al.  Prediction of unidentified human genes on the basis of sequence similarity to novel cDNAs from cynomolgus monkey brain , 2001, Genome Biology.

[6]  H. Wässle,et al.  Glutamate Receptors in the Rod Pathway of the Mammalian Retina , 2001, The Journal of Neuroscience.

[7]  Y. Suzuki,et al.  Assignment of 118 novel cDNAs of cynomolgus monkey brain to human chromosomes. , 2001, Gene.

[8]  B Bioulac,et al.  Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease , 2001, The Journal of Neuroscience.

[9]  Feng-Chi Chen,et al.  Genomic divergences between humans and other hominoids and the effective population size of the common ancestor of humans and chimpanzees. , 2001, American journal of human genetics.

[10]  Mark A Lane,et al.  Nonhuman primate models in biogerontology , 2000, Experimental Gerontology.

[11]  A. Varki,et al.  A chimpanzee genome project is a biomedical imperative. , 2000, Genome research.

[12]  S. Dunnett,et al.  The influence of excitotoxic basal ganglia lesions on motor performance in the common marmoset. , 2000, Brain : a journal of neurology.

[13]  D. McMurray,et al.  A nonhuman primate model for preclinical testing of new tuberculosis vaccines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  A. Hendrickx,et al.  Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents , 2000, Human & experimental toxicology.

[15]  N. Nathanson,et al.  Towards an AIDS vaccine: The role of nonhuman primates , 1999, Journal of medical primatology.

[16]  J Khan,et al.  DNA microarray technology: the anticipated impact on the study of human disease. , 1999, Biochimica et biophysica acta.

[17]  Rebecca K. Smith,et al.  Primate Conservation , 1998, Folia Primatologica.

[18]  C. Groves,et al.  Toward a phylogenetic classification of Primates based on DNA evidence complemented by fossil evidence. , 1998, Molecular phylogenetics and evolution.

[19]  S. P. Fodor,et al.  Evolutionary sequence comparisons using high-density oligonucleotide arrays , 1998, Nature Genetics.

[20]  C. Duyckaerts,et al.  Modeling the Relation Between Neurofibrillary Tangles and Intellectual Status , 1997, Neurobiology of Aging.

[21]  N. Élissa,et al.  Lack of malaria parasite transmission between apes and humans in Gabon. , 1997, The American journal of tropical medicine and hygiene.

[22]  M. Peschanski,et al.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.

[23]  P. Brown,et al.  Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Arthur,et al.  Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. , 1994, Journal of acquired immune deficiency syndromes.

[25]  Gary L. Wenk,et al.  A primate model of Alzheimer's disease , 1993, Behavioural Brain Research.

[26]  M. Herkenham,et al.  Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study , 1991, Neuroscience.

[27]  D. Price,et al.  Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease , 1991, Brain pathology.

[28]  D. Selkoe,et al.  Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. , 1991, The American journal of pathology.

[29]  David H. A. Fitch,et al.  Primate evolution at the DNA level and a classification of hominoids , 1990, Journal of Molecular Evolution.

[30]  J. Ahlquist,et al.  DNA hybridization evidence of hominoid phylogeny: A reanalysis of the data , 1990, Journal of Molecular Evolution.

[31]  H. Narabayashi,et al.  Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology , 1988, Brain Research.

[32]  B. Bioulac,et al.  MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study , 1985, Brain Research.

[33]  C. Rebert,et al.  Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey , 1984, Brain Research.

[34]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. King,et al.  Evolution at two levels in humans and chimpanzees. , 1975, Science.

[36]  J. Ahlquist,et al.  DNA hybridization evidence of hominoid phylogeny: Results from an expanded data set , 2005, Journal of Molecular Evolution.

[37]  Jon E. Ahlquist,et al.  The phylogeny of the hominoid primates, as indicated by DNA-DNA hybridization , 2005, Journal of Molecular Evolution.

[38]  J. Witkin,et al.  Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey , 2005, Psychopharmacology.

[39]  Takashi Kondo,et al.  GeneSpringTM: Tools for Analyzing Microarray Expression Data , 2001 .

[40]  K. Samson,et al.  Nonhuman primates: a critical role in current disease research. , 2001, ILAR journal.

[41]  D. Botstein,et al.  Exploring the new world of the genome with DNA microarrays , 1999, Nature Genetics.

[42]  S. P. Fodor,et al.  High density synthetic oligonucleotide arrays , 1999, Nature Genetics.

[43]  N. Nathanson,et al.  The role of nonhuman primates in the development of an AIDS vaccine. , 1999, AIDS.

[44]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.